Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Libman-Sacks Disease

paclitaxel has been researched along with Libman-Sacks Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandrescu, DT; Dasanu, CA1
Li, XP; Pan, HF; Wu, GC; Ye, DQ1
Baek, HJ; Chung, ES; Hong, KM; Kim, HA; Lee, EB; Song, YW1

Other Studies

3 other study(ies) available for paclitaxel and Libman-Sacks Disease

ArticleYear
Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.
    Southern medical journal, 2008, Volume: 101, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Ovarian Neoplasms; Paclitaxel

2008
Paclitaxel: friend or foe for systemic lupus erythematosus?
    Southern medical journal, 2009, Volume: 102, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Paclitaxel

2009
Paclitaxel reduces anti-dsDNA antibody titer and BUN, prolonging survival in murine lupus.
    International journal of immunopharmacology, 1998, Volume: 20, Issue:11

    Topics: Animals; Antibodies; Autoimmunity; Blood Urea Nitrogen; DNA; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Paclitaxel; Proteinuria

1998